| Zeit | Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 14.05. | Agios Pharmaceuticals, Inc.: Agios Pharmaceuticals to Present Clinical and Translational Data in Rare Blood Disorders at European Hematology Association 2024 Hybrid Congress | 2 | GlobeNewswire (USA) | ||
| 03.05. | Agios Pharmaceuticals, Inc.: Agios to Present at the RBC Capital Markets Global Healthcare Conference on May 14, 2024 | 3 | GlobeNewswire (USA) | ||
| 03.05. | Earnings call: Agios Pharmaceuticals outlines robust pipeline and financial health | 2 | Investing.com | ||
| 02.05. | Agios Pharmaceuticals Inc reports results for the quarter ended in March - Earnings Summary | 3 | Reuters | ||
| 02.05. | AGIOS PHARMACEUTICALS, INC. - 10-Q, Quarterly Report | 1 | SEC Filings | ||
| 02.05. | Agios Pharmaceuticals GAAP EPS of -$1.45 beats by $0.20, revenue of $8.19M misses by $0.18M | 2 | Seeking Alpha | ||
| 02.05. | Agios Pharmaceuticals, Inc.: Agios Reports Business Highlights and First Quarter 2024 Financial Results | 102 | GlobeNewswire (Europe) | - Topline Data Readout from the Phase 3 ENERGIZE-T Study of Mitapivat in Adults with Transfusion-Dependent Alpha- or Beta-Thalassemia now expected in Q2 2024 - - Announced Positive Results from the... ► Artikel lesen | |
| 02.05. | AGIOS PHARMACEUTICALS, INC. - 8-K, Current Report | 1 | SEC Filings | ||
| 18.04. | Agios Pharmaceuticals, Inc.: Agios to Webcast Conference Call of First Quarter 2024 Financial Results on May 2, 2024 | 4 | GlobeNewswire (USA) | ||
| 26.02. | Agios Pharmaceuticals Stock Earns IBD Stock Upgrade Again, Hitting 90-Plus RS Rating | 6 | Investor's Business Daily | ||
| 23.02. | Agios Pharmaceuticals Stock Earns RS Rating Upgrade; Hits Key Benchmark | 8 | Investor's Business Daily | ||
| 22.02. | Agios Pharmaceuticals, Inc.: Agios to Present at the TD Cowen 44th Annual Health Care Conference on March 4, 2024 | 2 | GlobeNewswire (USA) | ||
| 20.02. | Agios Pharmaceuticals, Inc. (AGIO) Q4 2023 Earnings Call Transcript | 3 | Insider Monkey | ||
| 16.02. | Earnings call: Agios Pharmaceuticals outlines robust pipeline and financial health | 2 | Investing.com | ||
| 15.02. | AGIOS PHARMACEUTICALS, INC. - 10-K, Annual Report | 1 | SEC Filings | ||
| 15.02. | Agios Pharmaceuticals GAAP EPS of -$6.33 misses by $0.07, revenue of $26.82M misses by $0.9M | 7 | Seeking Alpha | ||
| 15.02. | AGIOS PHARMACEUTICALS, INC. - 8-K, Current Report | 1 | SEC Filings | ||
| 15.02. | Agios Pharmaceuticals, Inc.: Agios Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Business Highlights | 180 | GlobeNewswire (Europe) | - Announced Positive Results from the Phase 3 ENERGIZE Study of Mitapivat in Adults with Non-Transfusion-Dependent Alpha- or Beta-Thalassemia - - Presented Positive Results from Phase 2 Portion of... ► Artikel lesen | |
| 14.02. | Agios Pharmaceuticals Q4 2023 Earnings Preview | 2 | Seeking Alpha | ||
| 14.02. | Earnings Preview: Agios Pharmaceuticals | 6 | Benzinga.com |
Seite:
1 2 Weiter >>
| Suchbegriffe der letzen 24 h | Anzahl |
|---|---|
| GAMESTOP | 2.779 |
| EVOTEC | 2.533 |
| TUI | 1.883 |
| NVIDIA | 1.629 |
| NEL | 1.302 |
| BAYER | 1.206 |
| SIEMENS ENERGY | 1.196 |
| PLUG POWER | 1.126 |
| RHEINMETALL | 1.104 |
| REDCARE PHARMACY | 866 |
| BYD | 861 |
| AIXTRON SE | 836 |
| DEUTSCHE BANK | 809 |
| COMMERZBANK | 795 |
| VOLKSWAGEN | 786 |
| RENK GROUP | 758 |
| MERCEDES-BENZ | 757 |
| AMC ENTERTAINMENT | 745 |
| DEUTSCHE LUFTHANSA | 697 |
| BARRICK GOLD | 689 |
| HEIDELBERGER DRUCK | 608 |
| SUPER MICRO COMPUTER | 601 |
| RWE | 574 |
| TESLA | 558 |
| BASF | 557 |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und
